BACKGROUND: Some patients operated by pancreaticoduodenectomy for resectable pancreatic head adenocarcinoma will present with a recurrence during the first year (early recurrence). OBJECTIVE: The aim of this study was to determine prognostic factors associated with early recurrence in a large retrospective study. METHODS: From January 1995 to November 2010, all patients operated by pancreaticoduodenectomy for pancreatic head adenocarcinoma in our institution were retrospectively included. Univariate and multivariate analyses were performed to determine factors associated with early recurrence. RESULTS: A total of 166 patients were included; 57 patients (34%) developed early recurrence. In univariate analysis, factors associated with early recurrence were perineural invasion (p = 0.0002), preoperative bilirubin (p = 0.01), lymph node ratio (LNR) ≥0.2 (p = 0.009), and T stage (p = 0.02). In multivariate analysis, perineural invasion (odds ratio [OR] 3.31; 95% confidence interval [CI] 1.42-7.72; p = 0.005), LNR ≥0.2 (OR 2.55; 95% CI 1.17-5.52; p = 0.02), and preoperative bilirubin (OR 1.04; 95% CI 1.01-1.07; p = 0.03) were independent factors associated with early recurrence. Perineural invasion was also associated with poor overall survival (p = 0.001) and poor disease-free survival (p = 0.07). CONCLUSION: In our study, perineural invasion (OR 3.31) is more accurate than T stage and lymph node status (OR 2.55) to predict early recurrence after pancreatoduodenectomy for pancreatic head adenocarcinoma.
BACKGROUND: Some patients operated by pancreaticoduodenectomy for resectable pancreatic head adenocarcinoma will present with a recurrence during the first year (early recurrence). OBJECTIVE: The aim of this study was to determine prognostic factors associated with early recurrence in a large retrospective study. METHODS: From January 1995 to November 2010, all patients operated by pancreaticoduodenectomy for pancreatic head adenocarcinoma in our institution were retrospectively included. Univariate and multivariate analyses were performed to determine factors associated with early recurrence. RESULTS: A total of 166 patients were included; 57 patients (34%) developed early recurrence. In univariate analysis, factors associated with early recurrence were perineural invasion (p = 0.0002), preoperative bilirubin (p = 0.01), lymph node ratio (LNR) ≥0.2 (p = 0.009), and T stage (p = 0.02). In multivariate analysis, perineural invasion (odds ratio [OR] 3.31; 95% confidence interval [CI] 1.42-7.72; p = 0.005), LNR ≥0.2 (OR 2.55; 95% CI 1.17-5.52; p = 0.02), and preoperative bilirubin (OR 1.04; 95% CI 1.01-1.07; p = 0.03) were independent factors associated with early recurrence. Perineural invasion was also associated with poor overall survival (p = 0.001) and poor disease-free survival (p = 0.07). CONCLUSION: In our study, perineural invasion (OR 3.31) is more accurate than T stage and lymph node status (OR 2.55) to predict early recurrence after pancreatoduodenectomy for pancreatic head adenocarcinoma.
Authors: Helmut Oettle; Stefan Post; Peter Neuhaus; Klaus Gellert; Jan Langrehr; Karsten Ridwelski; Harald Schramm; Joerg Fahlke; Carl Zuelke; Christof Burkart; Klaus Gutberlet; Erika Kettner; Harald Schmalenberg; Karin Weigang-Koehler; Wolf-Otto Bechstein; Marco Niedergethmann; Ingo Schmidt-Wolf; Lars Roll; Bernd Doerken; Hanno Riess Journal: JAMA Date: 2007-01-17 Impact factor: 56.272
Authors: Thierry Conroy; Françoise Desseigne; Marc Ychou; Olivier Bouché; Rosine Guimbaud; Yves Bécouarn; Antoine Adenis; Jean-Luc Raoul; Sophie Gourgou-Bourgade; Christelle de la Fouchardière; Jaafar Bennouna; Jean-Baptiste Bachet; Faiza Khemissa-Akouz; Denis Péré-Vergé; Catherine Delbaldo; Eric Assenat; Bruno Chauffert; Pierre Michel; Christine Montoto-Grillot; Michel Ducreux Journal: N Engl J Med Date: 2011-05-12 Impact factor: 91.245
Authors: Yaojun Zhang; Adam E Frampton; Charis Kyriakides; Jan J Bong; Nagy Habib; Raida Ahmad; Long R Jiao Journal: J Cancer Res Clin Oncol Date: 2012-03-04 Impact factor: 4.553
Authors: P Magistrelli; A Antinori; A Crucitti; A La Greca; R Masetti; R Coppola; G Nuzzo; A Picciocchi Journal: J Surg Oncol Date: 2000-05 Impact factor: 3.454
Authors: James Helm; Barbara A Centeno; Domenico Coppola; Marcovalerio Melis; Mark Lloyd; Jong Y Park; Dung-Tsa Chen; Mokenge P Malafa Journal: Cancer Date: 2009-09-15 Impact factor: 6.860
Authors: Mark B Slidell; David C Chang; John L Cameron; Christopher Wolfgang; Joseph M Herman; Richard D Schulick; Michael A Choti; Timothy M Pawlik Journal: Ann Surg Oncol Date: 2007-09-26 Impact factor: 5.344
Authors: Edward J Kim; Edgar Ben-Josef; Joseph M Herman; Tanios Bekaii-Saab; Laura A Dawson; Kent A Griffith; Isaac R Francis; Joel K Greenson; Diane M Simeone; Theodore S Lawrence; Daniel Laheru; Christopher L Wolfgang; Terence Williams; Mark Bloomston; Malcolm J Moore; Alice Wei; Mark M Zalupski Journal: Cancer Date: 2013-05-29 Impact factor: 6.860
Authors: Emily R Holthoff; Susanne K Jeffus; Ashita Gehlot; Rebecca Stone; Stephen W Erickson; Thomas Kelly; Charles M Quick; Steven R Post Journal: Am J Surg Pathol Date: 2015-08 Impact factor: 6.394
Authors: Lorenzo De Franco; Daniele Marrelli; Costantino Voglino; Carla Vindigni; Francesco Ferrara; Giulio Di Mare; Livio Iudici; Mario Marini; Franco Roviello Journal: Pathol Oncol Res Date: 2017-05-30 Impact factor: 3.201
Authors: V Secq; J Leca; C Bressy; F Guillaumond; P Skrobuk; J Nigri; S Lac; M-N Lavaut; T-T Bui; A K Thakur; N Callizot; R Steinschneider; P Berthezene; N Dusetti; M Ouaissi; V Moutardier; E Calvo; C Bousquet; S Garcia; G Bidaut; S Vasseur; J L Iovanna; R Tomasini Journal: Cell Death Dis Date: 2015-01-15 Impact factor: 8.469